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margin-derived STRO-1/MACS1 and MACS2 cell
populations
Karim M Fawzy El-Sayed1,2, Sebastian Paris3, Christian Graetz1, Neemat Kassem4, Mohamed Mekhemar1,
Hendrick Ungefroren5, Fred Fa¨ndrich5 and Christof Do¨rfer1
Recently, gingival margin-derived stem/progenitor cells isolated via STRO-1/magnetic activated cell sorting (MACS) showed remarkable
periodontal regenerative potential in vivo. As a second-stage investigation, the present study’s aim was to perform in vitro characterisation
and comparison of the stem/progenitor cell characteristics of sorted STRO-1-positive (MACS1) and STRO-1-negative (MACS2) cell
populations from the human free gingival margin. Cells were isolated from the free gingiva using a minimally invasive technique and were
magnetically sorted using anti-STRO-1 antibodies. Subsequently, the MACS1 and MACS2 cell fractions were characterized by flow
cytometry for expression of CD14, CD34, CD45, CD73, CD90, CD105, CD146/MUC18 and STRO-1. Colony-forming unit (CFU) and
multilineage differentiation potential were assayed for both cell fractions. Mineralisation marker expression was examined using real-time
polymerase chain reaction (PCR). MACS1 andMACS2 cell fractions showed plastic adherence. MACS1 cells, in contrast to MACS2 cells,
showed all of the predefined mesenchymal stem/progenitor cell characteristics and a significantly higher number of CFUs (P,0.01).
More than 95% of MACS1 cells expressed CD105, CD90 and CD73; lacked the haematopoietic markers CD45, CD34 and CD14, and
expressed STRO-1 and CD146/MUC18. MACS2 cells showed a different surface marker expression profile, with almost no expression of
CD14 or STRO-1, and more than 95% of these cells expressed CD73, CD90 and CD146/MUC18, as well as the haematopoietic markers
CD34 and CD45 and CD105. MACS1 cells could be differentiated along osteoblastic, adipocytic and chondroblastic lineages. In
contrast, MACS2 cells demonstrated slight osteogenic potential. Unstimulated MACS1 cells showed significantly higher expression of
collagen I (P,0.05) and collagen III (P,0.01), whereas MACS2 cells demonstrated higher expression of osteonectin (P,0.05; Mann–
Whitney). The present study is the first to compare gingival MACS1 and MACS2 cell populations demonstrating that MACS1 cells, in
contrast to MACS2 cells, harbour stem/progenitor cell characteristics. This study also validates the effectiveness of the STRO-1/MACS1
technique for the isolation of gingival stem/progenitor cells. Human free gingival margin-derived STRO-1/MACS1 cells are a unique
renewable source of multipotent stem/progenitor cells.
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INTRODUCTION
The gingiva is the component of the periodontium covering the tooth-
bearing alveolar bone and the necks of the teeth. One of its eminent
characteristics is its remarkable wound healing and regenerative capa-
city, with rapid reconstitution of the tissue architecture showing little,
if any, evidence of scarring.1 The multiple functions of gingival fibro-
blasts, their variable responsiveness to growth factors and their ability
to produce specific extracellular matrix proteins during the healing
process demonstrate that they represent a heterogeneous population
of cells.2–6 These properties also indicate the presence of a population
of stem/progenitor cells, similar to other periodontal components,
which gives rise to these heterogeneous cells.
Representing a key component of the periodontium, the free gin-
gival margin has a unique developmental origin, arising from the outer
layer of the dental follicle, the perifollicular mesenchyme,7 as well as
partly from the inner layer of the dental follicle, the dental follicle
proper,8 from which stem/progenitor cells have been isolated.9 In
addition, the free gingival margin partially arises from the periodontal
ligament cells,2 which themselves originate from the dental follicle
proper;7 periodontal ligament stem/progenitor cells have also been
obtained from this tissue10 (Figure 1a). In a recent study, porcine free
gingival margin-derived stem/progenitor cells, that were isolated via a
minimally invasive procedure and magnetically sorted using anti-
STRO-1 antibodies, demonstrated remarkable periodontal regenerative
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Figure 1 Schema of free gingival margin development, CFU assay, and flow cytometric analysis of the surface marker expression profile of the gingival margin-
derived cells. (a) Schema of free gingival margin development. (b) Schema of free gingival margin cell isolation. Microscopic appearance and colony formation: (c) phase
contrast microscopic appearance of the adherent tissue mass with outgrowing cells (first week) and (d) after the first cell passage. (e) Viability staining using fluorescein
diacetate–propidium iodide. The green colour indicates living cells, and the dead cells are labelled in red. (f) CFUs of MACS1 cells (arrows, crystal violet). (g) Phase
contrast microscopic appearance of the MACS1 cells (crystal violet). (h) Scattered appearance of the MACS2 cells (crystal violet) and (i) phase contrast microscopic
appearance of the MACS2 cells (crystal violet). (j) CFU assay of MACS1 and MACS2 cells (box-and-whisker plots with medians and quartiles). Significant differences are
marked with asterisks (n56, **P,0.01; Mann–Whitney). (k) Flow cytometric analysis of the surface marker expression profile of the MACS1 cells. (l) Flow cytometric
analysis of the surface marker expression profile of the MACS2 cells. CEJ, cemento-enamel junction; CFU, colony-forming unit; MACS, magnetic activated cell sorting.
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capacity in vivo.11 This finding clearly challenged the classical compart-
mentalisation theory declaring that the gingival connective tissue does
not contribute to periodontal regeneration and that it should be excluded
during guided tissue regeneration (GTR) techniques,12 instead showing
that this tissue harbours multipotent stem/progenitor cells with remark-
able regenerative potential. As a second-stage study, the aim of the pre-
sent study was to perform in vitro characterisation and comparison of the
stem/progenitor cell characteristics of magnetically sorted STRO-1-pos-
itive (magnetic activated cell sorting (MACS)1) and -negative (MACS2)
cell fractions isolated from the human free gingival margin.
MATERIAL AND METHODS
Isolation and culture of the tissues
After obtaining informed consent from patients (IRB Approval num-
ber D 444/10), healthy, partially impacted third molar teeth with free
gingival soft tissue collars were surgically removed from six individuals
(n56) at the Department of Oral Surgery of the Christian Albrechts
University, Kiel, Germany. The free gingival tissue collars were detached
(Figure 1b, dotted incision line), de-epithelized under magnification,
cut into small pieces (approximately 2 mm32 mm), rinsed several
times with Eagle’s minimum essential medium alpha modification
(Sigma-Aldrich GmbH, Hamburg, Germany) supplemented with
antibiotics (100 U?mL21 penicillin, 100 mg?mL21 streptomycin) and
1% amphotericin (all from Biochrom, Berlin, Germany) and placed
into dry 75 mL culture flasks (Sarstedt, Nu¨mbrecht, Germany) for
30 min to allow them to adhere to the bottoms of the flasks.
Subsequently, the basic medium, consisting of Eagle’s minimum essential
medium alpha modification supplemented with 15% foetal calf serum
(HyClone, Logan, UT, USA), 400 mmol?mL21 L-glutamine (Biochrom,
Berlin, Germany), 100 U?mL21 penicillin, 100 mg?mL21 streptomycin
and 1% amphotericin, was carefully added. The flasks were incubated
in 5% carbon dioxide at 37 6C, and the cells were allowed to grow. The
culture flasks were periodically checked using phase contrast inverted
microscopy, and the basic medium was changed three times per week.
After reaching 80%–85% confluence, the cells were washed
with 5 mL phosphate-buffered saline (PBS) (Biochrom, Berlin,
Germany). Two millilitres of 0.10% trypsin-ethylenediaminetetraace-
tic acid (EDTA) (Biochrom, Berlin, Germany) was added, and the
culture flasks were incubated for 1 min to detach the cells.
Subsequently, 5 mL of the basic medium was added. The medium
containing the cells was transferred to sterile Falcon 50 mL polypro-
pylene conical tubes (Becton Dickinson, Heidelberg, Germany) and
centrifuged at 2 000g for 10 min. The supernatant was discarded, and
the cells were re-suspended in 2 ml of the basicmedium. The cells were
counted and tested for viability using Trypan Blue (Sigma-Aldrich
GmbH, Hamburg, Germany) and were finally seeded in basic medium
at a density of 30 cells?cm22 in 75 mL culture flasks; the flasks were
incubated in 5% carbon dioxide at 37 6C.
Fluorescein diacetate–propidium iodide staining
To determine the viability of the seeded cells, fluorescein diacetate–pro-
pidium iodide) staining was used. Briefly, stock solutions of fluorescein
diacetate (5 mg?mL21 in acetone) and propidium iodide (0.02 mg?mL21
in Dulbecco’s PBS) were stored at 4 6C in the dark. Staining was per-
formed by adding a solution containing 2 mg of fluorescein diacetate and
0.6 mg of propidium iodide to the cells and allowing them to stand for 3
min. The cell viability of was investigated using a fluorescence microscope
with 520 nm and 590 nm filters.
Immunomagnetic cell sorting
After the first-passage cells reached 80%–85% confluence, they were
subjected to immunomagnetic cell sorting using STRO-1 (BioLegend,
San Diego, CA, USA) and anti-IgM MicroBeads (Miltenyi Biotec,
Bergisch Gladbach, Germany) according to the manufacturers’
instructions (MACS; Miltenyi Biotec, Bergisch Gladbach, Germany).
The positive (MACS1 cells) and the negative (MACS2 cells) sorted
cell fractions were seeded in basic medium in new 75 mL flasks at a
density of 30 cells?cm22.
Flow cytometric analysis
After reaching confluence, samples from second-passageMACS1 cells
and second-passage MACS2 cells were characterized by flow cytome-
try using antibodies specific for CD14, CD34, CD45, CD73, CD90 and
CD105 (all from Becton Dickinson, Heidelberg, Germany), CD146/
MUC18 (eBioscience, NatuTec, Frankfurt, Germany) and STRO-1
(BioLegend, San Diego, CA, USA). The binding of the primary anti-
bodies and the corresponding isotype controls was performed accord-
ing to standard protocols using FcR Blocking Reagent (Miltenyi Biotec,
Bergisch Gladbach, Germany) and was evaluated with FACSCalibur
E6370 and FACSComp 5.1.1 software (Becton Dickinson, Heidelberg,
Germany).
Colony-forming unit assay
To assess their colony-forming efficiency, MACS1 cells were cultured
in basic medium at a density of 1.63 cells?cm21. Aggregates of 50 or
more cells were scored as colonies. As controls, MACS2 cells were
cultured under the same conditions. On the twelfth day, the cultures
were fixed with 4% formalin and stained with 0.1% crystal violet, and
the numbers of colonies were statistically evaluated.
Multilineage differentiation potential
Osteogenic differentiation. To test for osteogenic differentiation
potential, third-passage MACS1 cells and third-passage MACS2 cells
were cultured on six-well culture plates in osteogenic inductive me-
dium (PromoCell, Heidelberg, Germany) at a density of 23104 cells
per well. As controls, MACS1 cells and MACS2 cells were cultured in
basic medium. The media were renewed three times per week. At day
14, the cell cultures were stained with Alizarin Red (Sigma-Aldrich
GmbH, Hamburg, Germany)13 to label calcified deposits, while the
expression of runt-related-transcription-factor-2 (Cbfa1/Runx2) and
alkaline phosphatase (ALP) was assessed using real-time polymerase
chain reaction (PCR; LightCycler; Roche Molecular Biochemicals,
Indianapolis, IN, USA).
Adipogenic differentiation. To test the adipogenic differentiation
potential, third-passage MACS1 cells and third-passage MACS2 cells
were cultured on six-well culture plates in adipogenic inductive med-
ium (PromoCell, Heidelberg, Germany) at a density of 33105 cells per
well. As controls,MACS1 cells andMACS2 cells were cultured in basic
medium. The media were renewed three times per week. The presence
of lipid drops was evaluated by staining the cells with Oil Red O
(Sigma-Aldrich GmbH, Hamburg, Germany),13 and the expression
of peroxisome proliferator-activated receptor gamma (PPAR-c; an
early adipogenicmarker) and lipoproteinlipase (LPL; a late adipogenic
marker) was assessed by PCR at day 21.14
Chondrogenic differentiation. To test the chondrogenic differenti-
ation potential, third-passage MACS1 cells and third-passage MACS2
cells were incubated with chondrogenic inductive medium (PromoCell,
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Heidelberg, Germany) in 1.5 mL Eppendorf tubes (Eppendorf,
Hamburg, Germany) at a density of 33104 cells per tube. As controls,
MACS1 cells and MACS2 cells were cultured in basic medium. The
media were renewed three times per week. Chondrogenic differentiation
was evaluated at day 35 by staining glycosaminoglycans with Alcian Blue
(Sigma-Aldrich GmbH, Hamburg, Germany)13 and by testing for the
expression of aggrecan (ACAN), also known as cartilage-specific pro-
teoglycan core protein.
RNA extraction and cDNA synthesis
RNA extraction was performed on MACS1 cells and MACS2 cells
using an RNeasy kit (Qiagen, Hilden, Germany) according to the
manufacturer’s instructions. The obtained RNA was purified using
RNase-free-DNase (Promega, Mannheim, Germany) and quantified
photometrically. Complementary cDNA was synthesized from 1–13 mL
of RNA (1 mg?mL21) by reverse transcription using a SuperScript reverse
transcription kit (Qiagen, Hilden, Germany) according to the manufac-
turer’s instructions (Mastercycler gradient; Eppendorf, Hamburg,
Germany). Real-time PCR (LightCycler; Roche Molecular Biochemicals,
Indianapolis, IN, USA) was performed as previously described15 using
the primers in Table 1.
Statistical analysis
The Shapiro–Wilk test was used to evaluate the normality of the data
distribution. Differences in colony-forming unit (CFU) counts and in
the mRNA expression of all tested genes between the MACS1 and
MACS2 cells were examined using the nonparametric Mann–Whitney
test with SPSS software (SPSS version 11.5; SPSS, Chicago, IL, USA).
The level of significance was set at P50.05.
RESULTS
Phase contrast inverted microscopy and fluorescein diacetate–
propidium iodide staining
Following the initial adherence phase, cells grew out of the gingival
tissue masses (Figure 1c). Cells formed adherent fibroblast-like clusters
(Figure 1d) and were viable when tested with fluorescein diacetate–
propidium iodide staining (Figure 1e).
Colony formation
Twelve days after seeding, CFUs were observed in the MACS1 cell
cultures (Figure 1f and 1g). In contrast, MACS2 cells seeded under the
same culture conditions showed a more diffuse distribution (Figure 1h
and 1i). The number of CFUs was significantly higher in the MACS1
cell cultures, with a median of 5 CFUs per 20 MACS1 cells seeded,
than in the MACS2 cell cultures (P,0.01; Mann–Whitney, Figure 1j).
Flow cytometric analysis
MACS1 cells were negative for CD14, CD34 and CD45 and positive for
CD73, CD90, CD105, CD146/MUC18 and STRO-1. The expression of
CD73, CD90 and CD105 was above 95% (Figure 1k). MACS2 cells
showed almost no expression of CD14 and STRO-1, .95% expression
of CD73, CD90 and CD146/MUC18 in addition to the positive expres-
sion of the haematopoietic markers CD34, CD45 and CD105 (Figure 1l).
Multilineage differentiation potential
Osteogenic differentiation of MACS1 cells was demonstrated by
the formation of calcified deposits labelled with Alizarin Red and
by the significantly higher expression of Cbfa1/Runx2 (P,0.05;
Mann–Whitney) and ALP (P,0.01; Mann–Whitney) than in the
controls (Figure 2a–d). Adipogenic differentiation of MACS1 cells
resulted in the formation of lipid droplets that were positively
stained with Oil Red O and in the significantly higher expression
of PPAR-c (P,0.01; Mann–Whitney) and LPL (P,0.01; Mann–
Whitney) than in the controls (Figure 2e–h). Chondrogenic differ-
entiation of MACS1 cells resulted in the formation of glycosami-
noglycans positively stained with Alcian Blue and in the higher
expression of ACAN (P,0.05; Mann–Whitney), than in the con-
trols (Figure 2i–k). MACS2 cells showed no Alizarin Red-positive
deposits and a low level of expression of ALP (P,0.05; Mann–
Whitney, Figure 2l–o). Adipogenic differentiation was not evident
in MACS2 cells (Figure 2p–s). Chondrogenic differentiation of
MACS2 cells was not demonstrated, as was evident by the lack
of expression of the cartilage-specific proteoglycan core protein
ACAN. MACS2 cells and their controls (in sharp contrast to
Table 1 Primer sequences used for real-time PCR
Gene GenBank accession number Long/short Forward primer Reverse primer Product size/bp
Alkaline phosphatase NM_000478.4 Long CCACGTCTTCACATTTGGTG AGACTGCGCCTGGTAGTTGT 196
Short CCCGTGGCAACTCTATCTTT CATGGAGACATTCTCTCGTTCA 131
Osteopontin J04765.1 Long CCCACAGACCCTTCCAAGTA ACACTATCACCTCGGCCATC 279
Short ACAGCCAGGACTCCATTGAC GGGGACAACTGGAGTGAAAA 161
Osteonectin M25746.1 Long CTCTTTAACCCTCCCCTTCG ATGGGCAAAGCTACAAATGG 230
Short TGGATGGTTTGTTGTTCTGC GGGACTATTAATGCGTGTGGA 153
Collagen I NM_000089.3 Long CTGCAAGAACAGCATTGCAT GGCGTGATGGCTTATTTGTT 203
Short ATGAGGAGACTGGCAACCTG CAATGATTGTCTTTCCCCATT 150
Collagen III NM_000090.3 Long TACGGCAATCCTGAACTTCC GTGTGTTTCGTGCAACCATC 245
Short CATCTGGCATTCCTTCGACT TGCTATTTCCTTCAGCCTTGA 163
Cbfa1/Runx2 NM_001024630.3 Long TATGGAGTGCTGCTGGTCTG TCTGGCCTTCCACTCTCAGT 280
Short CACTCTGGCTTTGGGAAGAG GCAGTTCCCAAGCATTTCAT 181
PPAR-c NM_138712.3 Long GCTGTGCAGGAGATCACAGA GGGCTCCATAAAGTCACCAA 225
Short GCCAAAAGCATTCCTGGTT TCCCTTGTCATGAAGCCTTG 155
LPL NM_000237.2 Long GGGCATGTTGACATTTACCC AGCCCTTTCTCAAAGGCTTC 221
Short CAGCCAGGATGTAACATTGG TGGAACTGCACCTGTAGGC 163
ACAN NM_001135.3 Long GTGGAATGCAGAGGTGGTTT ACAGCTGGGGACATTAGTGG 189
Short AATCTTCTCTGCTGGCCTCA GCTCCCTGGGTCTGGAGTAG 116
GAPDH NM_002046 Long CCTGACCTGCCGTCTAGAAA TACTCCTTGGAGGCCATGTG 276
Short TCAAGAAGGTGGTGAAGCAG CCCTGTTGCTGTAGCCAAAT 198
ACAN, aggrecan; Cbfa1/Runx2, Runt-related transcription factor 2; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; LPL, lipoproteinlipase; PCR, polymerase chain
reaction; PPAR-c, peroxisome proliferator-activated receptor gamma.
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Figure 2 Multilineage differentiation potential of MACS1 cells and MACS2 cells. Alizarin Red staining of the osteogenically stimulated MACS1 cells (a) and their
controls (b). Cbfa1/Runx2 (c) and ALP (d) expression in stimulated and unstimulated MACS1 cells (box-and-whisker plots with medians and quartiles). Oil Red O
staining of the adipogenically stimulated MACS1 cells (e) and their controls (f). PPAR-c (g) and LPL (h) expression in stimulated and unstimulated MACS1 cells (box-
and-whisker plots with medians and quartiles). Alcian Blue staining of the chondrogenically stimulated MACS1 cells (i) and their controls (j). ACAN (k) expression in
stimulated and unstimulated MACS1 cells. Alizarin Red staining of the osteogenically stimulated MACS2 cells (l) and their controls (m). Cbfa1/Runx2 (n) and ALP (o)
expression in stimulated and unstimulated MACS2 cells (box-and-whisker plots with medians and quartiles). Oil Red O staining of the adipogenically stimulated
MACS2 cells (p) and their controls (q). PPAR-c (r) and LPL (s) expression in stimulated and unstimulated MACS2 cells (box-and-whisker plots with medians and
quartiles). Alcian Blue staining of the chondrogenically stimulated MACS2 cells (t) and their controls (u). ACAN (v) expression in stimulated and unstimulatedMACS2
cells (box-and-whisker plots with medians and quartiles). Significant differences are marked with asterisks (n56, *P,0.05, **P,0.01; Mann–Whitney). ACAN,
aggrecan; ALP, alkaline phosphatase; Cbfa1/Runx2, runt-related-transcription-factor-2; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; LPL, lipoproteinli-
pase; MACS, magnetic activated cell sorting; PPAR-c, peroxisome proliferator-activated receptor gamma.
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MACS1 cell controls) showed uniform staining of glycosaminogly-
cans (Figure 2t–v). Chondrogenic lacuna-like structures visible in
the stimulated MACS1 cells (Figure 2i) were absent from the sti-
mulated MACS2 cells (Figure 2t).
Gene expression profile
In general, early osteogenic markers such as collagens I and III were
more highly expressed than were osteopontin and osteonectin in both
cell populations. MACS1 cells tended to show higher expression of early
osteogenic markers such as ALP, with significantly different levels
reached for collagens I (P,0.05) and III16 (P,0.01). MACS2 cells
showed a tendency towards higher expression of late osteogenic markers
such as osteonectin (P,0.05) and osteopontin, and the expression of
collagens I and III and of ALP was lower than inMACS1 cells (Figure 3).
DISCUSSION
The free gingival margin constitutes a distinctive, as well as a pivotal,
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Figure 3 Expression profile of osteogenic markers. mRNA expression profiles for collagen I, collagen III, alkaline phosphatase, osteonectin and osteopontin (box-
and-whisker plots with medians and quartiles) in MACS1 and MACS2 cells. Significant differences are marked with asterisks (n56, *P,0.05, **P,0.01; Mann–
Whitney). GAPDH, glyceraldehyde 3-phosphate dehydrogenase; MACS, magnetic activated cell sorting.
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anatomical terms. This tissue is widely available for use and is routi-
nely removed during dental crown lengthening and periodontal
surgical procedures. In a recent study, porcine free gingival margin-
derived STRO-1/MACS1 stem/progenitor cells isolated via a min-
imally invasive procedure were tested and demonstrated remarkable
periodontal regenerative capacity in vivo.11 The aim of the present
study was to perform in vitro characterisation and comparison of
the stem/progenitor cell characteristics of the MACS1 and MACS2
cell populations of the human free gingival margin.
Recent investigations of gingival stem/progenitor cells demonstrated
their many promising qualities for tissue engineering, including an
immunomodulatory property,17 as well as compatibility with alginate
hydrogel microbead scaffolds.18 Earlier studies reported the isolation of
progenitor cells from oral soft tissues,19 including the rugae and incisive
papillae of the palate,20 the maxillary tuberosity,21 the oral mucosa,22
the whole,23 the attached gingiva24–26 and hyperplastic gingiva.27 Along
with the difference in anatomical location, the free gingival margin
partly differs in its developmental origin from the previously described
soft tissue sources. In addition to a common neural crest ectomesench-
ymal origin lined by ectoderm for all oral soft tissues, the inner layer of
the dental follicle, the dental follicle proper,8 the outer layer of the
dental follicle, the perifollicular mesenchyme7 and the periodontal liga-
ment cells2 are suggested to participate in the development of the gin-
gival connective tissues at the free gingival margin of the tooth, unlike
the non-tooth-bearing soft tissues of the oral cavity, which are anato-
mically devoid of dental follicle and periodontal cells. Developmentally,
upon tooth eruption, the lamina propria of the free gingival margin is
thought to be formed from cells stemming from the outer layer of the
dental follicle.7 Nevertheless, earlier studies demonstrated the presence
of fibroblasts stemming from the inner layer of the dental follicle in
the free gingival lamina propria at the cemento-enamel junction8
and further suggested that the dentogingival fibre system originates
in part from periodontal ligament cells.2 The developmental con-
tribution provided by the dental follicle proper and the periodontal
ligament cells to the perifollicular mesenchyme accounts for the
anatomical distinctiveness of the free gingival margin from the
previously investigated oral soft tissues.
Similar to the first-stage in vivo study,11 the putative stem cell mar-
ker STRO-1, which was implemented to isolate and purify bone mar-
row stromal stem cells28 and alveolar bone proper-derived stem/
progenitor cells29 using immunomagnetic cell selection, was used in
the current study to isolate multipotent postnatal stem/progenitor
cells (MACS1 cells) from heterogeneous gingival connective tissue
cells (MACS2 cells). This was based on the fact that the latter, in
contrast to the targeted multipotent stem/progenitor cells, do not
express the distinctive STRO-1 stem/progenitor cell marker.
TheMACS1 cell fraction showed all of the previously defined classical
characteristics of multipotent postnatal stem/progenitor cells.13,30–31
Regarding the surface marker expression profile, the results showed
that MACS1 cells were positive for CD73, CD90, CD105 (all above
95%), CD146/MUC18 and STRO-1, and negative for CD14, CD45
and CD45, in accord with the marker expression profile defined for
multipotent stromal cells in the International Society for Cellular
Therapy position statement.13 The level of STRO-1 expression was
comparable to that observed in the porcine cells in the in vivo study.32
The decrease in the level of STRO-1 expression after the magnetic
sorting step has been previously described29,33 and suggests a possible
downregulation of the ‘second tier’33 surface marker STRO-1 during
the cells’ time in culture34 before they reach confluence and attain an
adequate cell count to be submitted to flow cytometric analysis. Despite
this decrease in expression during culture, the employment of the
STRO-1/MACS1 technique resulted in the selection of MACS1 cells
that showed all of the ‘first tier’33 stem/progenitor cell surface markers
noted in the International Society for Cellular Therapy’s predefined
percentages and constellation.13 The selected MACS1 cells demon-
strated remarkable CFU capacity and showed multilineage differenti-
ation potential, which was evident by their differentiation along the
osteogenic, adipogenic and chondrogenic lineages. Finally, unstimu-
lated MACS1 cells expressed all of the tested markers for mineralized
tissue.
In contrast, the MACS2 cells lacked many of the predefined stem/
progenitor cell characteristics,13,30–31 with a different surface marker
expression profile from MACS1 cells and almost no expression of
CD14 and STRO-1, .95% expression of CD73, CD90 and CD146/
MUC18, positive expression of the haematopoietic markers CD34 and
CD45, which are not normally expressed in mesenchymal stem/pro-
genitor cells, and CD105 expression below the predefined cutoff of
95%.13 No multilineage differentiation potential was evident in
MACS2 cells apart from an up-regulation of ALP mRNA expression
following osteogenic induction. The uniform staining of glycosami-
noglycans observed in the cultures of chondrogenically stimulated
MACS2 cells and their controls (in sharp contrast to the MACS1 cell
controls) demonstrates the fact that MACS2 cells harbour the differ-
entiated/committed population of gingival connective tissue cells,
which normally lay down glycosaminoglycans (which stain positive
for Alcian Blue) as a part of their normal gingival extracellular con-
nective tissuematrix production. This positive staining further under-
lines the fact that theMACS1 cell controls harboured undifferentiated
stem/progenitor cells that were unable to lay down extracellular glyco-
saminoglycan matrix components in the basic medium. Chondrogenic
lacunae-like structures evident in the stimulated MACS1 cells were
absent from the stimulated MACS2 cells. Expression of the cartilage-
specific proteoglycan core protein ACAN was also absent from the
MACS2 cells.
The common standard markers for mineralized tissue, which are
usually used as hallmarks for the identification of multipotent post-
natal stem/progenitor cells, including adipose-derived stromal cells35
and bone marrow stromal stem cells,36 were assessed for in the human
free gingival margin-derived stem/progenitor cells. Indeed, in the pre-
sent study, both the free gingival margin-derived stem/progenitor cells
(MACS1 cells) and the gingival connective tissue cells (MACS2 cells)
expressed transcripts encoding most of the tested mineralized tissue
markers, albeit in different quantities.
In line with their gingival origin, collagen types I and III were
expressed at substantially higher levels in both MACS1 and MACS2
cells than were osteonectin and osteopontin.31–32 Significantly higher
levels of collagen types I and III were expressed inMACS1 cells than in
MACS2 cells, along with a tendency to express more ALP. Osteonectin,
although minimally expressed in both cell types, was expressed at
higher levels inMACS2 cells. This is in accord with the results of earlier
studies that reported low expression of osteonectin37–38 and osteopon-
tin33 in mature gingival connective tissue. The elevated expression of
the late markers osteopontin and osteonectin by the MACS2 cells
could be considered an indicator of their more differentiated/commit-
ted cellular states39–41. These findings are consistent with those of
earlier studies on mesenchymal stem/progenitor cells and the relation-
ship of their temporal expression of mineralized tissue markers to their
cellular developmental process. In terms of matrix synthesis, immature
cells are expected to express high levels of early mineralized tissue
markers, such as collagen. When the expression of most of the early
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markers, including collagen, decreases, then the expression of late
osteogenic markers increases, denoting a shift from an immature to
a more differentiated/committed cellular state39–41. In this context, the
difference in mineralized tissue marker expression between the imma-
ture free gingival margin-derived stem/progenitor cells (MACS1 cells)
and the more differentiated/committed gingival connective tissue cells
(MACS2 cells) can be explained. Whether a time-dependent quan-
tification of the shift in the marker expression profile could be clinically
employed to indicate the developmental stage of gingival/periodontal
cells remains a very interesting point to be investigated.
CONCLUSION
The human free gingival margin provides a readily accessible and
renewable source of multipotent postnatal stem/progenitor cells that
can easily be obtained for cellular approaches for periodontal and
other tissues’ regeneration. The present results demonstrate that the
MACS1 cell population, in contrast to the MACS2 population, har-
bours cells with stem/progenitor cell characteristics, and validate the
effectiveness of the STRO-1/MACS1 technique for the isolation of free
gingival stem/progenitor cells.
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